TC BioPharm (Holdings) plcTC BioPharm (Holdings) plcTC BioPharm (Holdings) plc

TC BioPharm (Holdings) plc

No trades
See on Supercharts
Market capitalization
‪4.63 M‬USD
‪−7.34 M‬USD
Beta (1Y)
11.53

About TC BioPharm (Holdings) plc

CEO
Bryan Kobel
Headquarters
Motherwell
Employees (FY)
41
Founded
2013
FIGI
BBG0156K9VX2
TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.